dsm-firmenich
-
dsm-firmenich proposes Richard Ridinger as new chairman as Thomas Leysen steps down
The company said its ‘strategic direction’ is ‘fully set,’ prompting Leysen’s decision to step down and devote more time to his other corporate and non-profit mandates.
-
dsm-firmenich beats Q2 forecasts as sales growth accelerates to 6%
The ingredients manufacturer reported strong growth in fragrances and food ingredients while confirming plans to cut around 1,000 jobs worldwide.
-
dsm-firmenich acquires Verax platform to strengthen AI-driven livestock analytics
Verax™ was first introduced for broilers, where it has been credited with enhancing decision-making and reducing reliance on antibiotics.
-
dsm-firmenich completes US$10M upgrade at USA premix facility
The upgraded Schenectady facility gives customers greater confidence in an increasingly demanding regulatory and commercial environment.
-
dsm‑firmenich expands HMO portfolio across Asia
The company continues its regulatory success in Asia’s early life nutrition market with approval of four new HMOs in Malaysia and Thailand alongside commercial authorization of its 3’-SL ingredient in China
